Dalton Bioanalytics
PrivateLast Round
Seed
Apr 1, 2020
Total Funding Raised
$500,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Dalton Bioanalytics operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Seed round in April 2020.
Dalton Bioanalytics is a biotechnology company that provides multi-omics analytical services using its proprietary Omni-MS platform to profile proteins, lipids, metabolites, and other molecules in a single assay.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dalton Bioanalytics Comparables
Compare Dalton Bioanalytics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapient | 89% | |
| Metware Biotechnology | 86% | |
| Creative Proteomics | 83% |
For institutional investors. Book with your work email.
Dalton Bioanalytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2020 | ||||
| Accelerator | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dalton Bioanalytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IndieBio | Seed, Accelerator |
| UCLA Anderson Venture Accelerator | Seed |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 271% MoM, reaching 4.3K.
- Jul 26, 2026
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
Dalton Bioanalytics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dalton Bioanalytics's valuation, stock price, and market status.
Is Dalton Bioanalytics a public or private company?
Dalton Bioanalytics is a private company.
What is the current stock price of Dalton Bioanalytics?
Dalton Bioanalytics is a private company, so its shares have no public market price. Caplight tracks Dalton Bioanalytics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dalton Bioanalytics worth (valuation)?
Valuation information for Dalton Bioanalytics is not publicly available.
Can I buy Dalton Bioanalytics stock?
Dalton Bioanalytics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dalton Bioanalytics's last funding round?
Dalton Bioanalytics's most recent funding round was Seed on April 1, 2020.
Who are the main investors in Dalton Bioanalytics?
Key investors in Dalton Bioanalytics include IndieBio.
Will Dalton Bioanalytics IPO soon?
No public IPO plans have been announced for Dalton Bioanalytics.
How can I track Dalton Bioanalytics secondary market activity?
Caplight tracks bids, offers, and trades in Dalton Bioanalytics's shares on secondary markets.